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In Brief
Bacterial components are recognized by
the immune system through activation of
the inflammasome, eventually causing
processing of the proinflammatory cyto-
kine interleukin-1b (IL-1b) through the
protease caspase-1. Hildebrand et al.
describe a mechanism that bypasses in-
flammasome activation. Instead, Pas-
teurella multocida toxin stimulates the
expression of the serine protease gran-
zyme A that mediates maturation of IL-
1b into a bioactive cytokine.
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Bacterial components are recognized by the immune
system through activation of the inflammasome,
eventually causing processing of the proinflamma-
tory cytokine interleukin-1b (IL-1b), a pleiotropic
cytokine and one of the most important mediators
of inflammation, through the protease caspase-1.
Synthesis of the precursor protein and processing
into its bioactive form are tightly regulated, given
that disturbed control of IL-1b release can cause
severe autoinflammatory diseases or contribute to
cancer development. We show that the bacterial
Pasteurella multocida toxin (PMT) triggers Il1b gene
transcription in macrophages independently of Toll-
like receptor signaling through RhoA/Rho-kinase-
mediated NF-kB activation. Furthermore, PMT
mediates signal transducer and activator of tran-
scription (STAT) protein-controlled granzyme A
(a serine protease) expression in macrophages. The
exocytosed granzymeA enters target cells andmedi-
ates IL-1b maturation independently of caspase-1
and without inducing cytotoxicity. These findings
show that macrophages can induce an IL-1b-initi-
ated immune response independently of inflamma-
some activity.
INTRODUCTION
Interleukin-1b (IL-1b) is mainly produced by blood monocytes
and macrophages and plays an important role in the host’s de-
fense against microbial infection and tissue injury. IL-1b is also
involved in autoinflammatory diseases, such as rheumatoid
arthritis (Bresnihan et al., 1998), and high levels of IL-1b are asso-
ciated with multiple myeloma (Carter et al., 1990). Various mech-
anisms regulate the production and activity of the cytokine from910 Cell Reports 9, 910–917, November 6, 2014 ª2014 The Authorsthe processing of the 31 kDa, marginally active IL-1b precursor
into the bioactive 17 kDa hormone, to its release from secretory
lysosomes (Eder, 2009). The most extensively studied IL-
1b-converting enzyme (ICE) and mediator of pyroptosis is
caspase-1 (Kepp et al., 2010). Caspase-1 is an intracellular
cysteine protease that cleaves human IL-1b between Asp 116
and Ala 117 when assembled in a protein platform called the in-
flammasome (Latz et al., 2013). The serine protease granzyme A
(GrzA) was also shown to convert in vitro translated human IL-1b
through cleavage at Arg 120 (Irmler et al., 1995), but the biolog-
ical relevance has not been proven yet.
Pasteurella multocida is a Gram-negative, facultatively anaer-
obic bacillus. Some of the serotype A and D strains produce a
protein toxin called Pasteurella multocida toxin (PMT) (Harper
et al., 2006). PMT is the major virulence factor for porcine atro-
phic rhinitis, which is characterized by nasal bone resorption
due to increased osteoclast proliferation and inhibition of bone
regeneration through osteoblasts (Kubatzky et al., 2013). PMT
is an AB toxin and activates the heterotrimeric G proteins Gaq,
Ga13, and Gai (Orth et al., 2013) through deamidation of a gluta-
mine residue required for guanosine triphosphate hydrolysis
(Orth et al., 2009).
Here, we show that PMT induces pro-IL-1b production and its
maturation in macrophages in the absence of pyroptosis. The
toxin stimulates Il1b gene transcription by inducing nuclear fac-
tor-kappa B (NF-lB) via RhoA. Moreover, PMT stimulates GrzA
expression through activation of signal transducer and activator
of transcription (STAT) proteins. Exocytosed GrzA enters target
cells without inducing cytotoxicity and mediates processing of
mouse and human pro-IL-1b into a bioactive cytokine indepen-
dently of caspase-1 and the inflammasome.
RESULTS
PMT Induces Transcription and Processing of Pro-IL-1b
We stimulated RAW264.7 cells with wild-type PMT (PMTwt), a
PMT mutant without catalytic activity (PMT C1165S) (Ward
et al., 1998), heat-inactivated wild-type toxin (PMT DT), or
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Figure 1. PMT Induces Transcription and
Processing of Pro-IL-1b
RAW264.7 cells were stimulated with 6.5 nM
PMTwt and PMT C1165S for 18 hr or with LPS
(100 ng/ml) for 3 hr.
(A) Quantitative RT-PCR using primers for Il1b was
performed (mean ± SD; n = 3).
(B) Cells were stimulated with PMTwt and PMT
mutants (18 hr) or with LPS/ATP (100 ng/ml,
4 hr; 5 mM, 2 hr) and western blots were performed
(n = 3).
(C) Released IL-1b was measured with ELISAs.
The indicated SDwas calculated from triplicates of
one experiment, n = 3.
Additional controls of the experimental setup can
be found in Figure S1.lipopolysaccharide (LPS) as a positive control. Figure 1A shows
that the induction of Il1b gene expression is comparable be-
tween LPS and PMTwt-treated cells. To test whether PMTwt is
subsequently able to stimulate processing of pro-IL-1b, we pro-
duced lysates including the supernatant of cells stimulated with
PMTwt, PMT C1165S, PMT DT or LPS/ATP and performed west-
ern blot analysis and ELISA assays (Figures 1B and 1C). The data
show that PMTwt is an equally potent activator of IL-1b
compared to the combination of LPS and ATP. To ensure spec-
ificity, PMT preparations had been tested for purity and activity
(Figures S1A and S1B). For RAW264.7 cells, expression of the in-
flammasome component Asc had been confirmed (Figure S1C).
PMT Induces Production of Pro-IL-1b Independently of
TLR-Signaling through RhoA/ROCK Pathway-Activated
NF-lB
The transcription of Il1b is regulated by the transcription factor
NF-lB (Cogswell et al., 1994). Preparations of nuclear fractions
from RAW264.7 cells confirmed that PMT induces the transloca-
tion of the NF-lB subunit p65 to the nucleus (Figure 2A), and
electrophoretic mobility shift assays (EMSAs) (Figure 2B) corrob-
orated that PMT activates DNA binding of NF-lB.
Many bacterial products activate NF-lB through stimulation of
Toll-like receptors (TLRs) (Doyle and O’Neill, 2006). To test
whether PMT-triggered NF-lB activation is dependent on TLR
signaling, we generated bone marrow-derived macrophages
(BMDMs) from the bone marrow of Myd88- and Trif-deficient
mice. LPS did not induce Il1b transcription in MyD88-deficient
BMDMs and, consequently, no secreted IL-1b was detected
(Figures 2C and 2E). On the other hand, PMT induces Il1b tran-
scription (Figure 2C) and IL-1b release (Figure 2E) independently
of MyD88, indicating that the TLR pathway is not involved. In
TRIF-deficient BMDMs, both LPS- and PMT-stimulated cellsCell Reports 9, 910–917,were able to trigger transcription and
secretion of IL-1b (Figures 2D and 2F),
suggesting that TRIF does not play a
major role in IL-1b production.
The small GTPaseRhoA, a downstream
target of PMT (Figure S1C), can induce
NF-lB-mediated gene transcription (Shi-
mizu et al., 2007; Teusch et al., 2004). In-hibition of the RhoA effector kinase ROCK (Rho kinase) with the
inhibitor LY27632 prevented the activation of an NF-lB lucif-
erase reporter (Figure 2G), and western blot analysis confirmed
the inhibition of pro-IL-1b expression and a decrease of IL-1b
release after LY27632 treatment (Figure 2H).
PMT-Triggered Processing of Pro-IL-1b Is Caspase-1
Independent
The active form of IL-1b-converting enzyme caspase-1 contains
two heterodimers of p20 and p10 subunits. Figure 3A shows that
only LPS/ATP, but notPMT, inducesprocessingof caspase-1. To
verify that caspase-1 is not responsible for PMT-induced IL-1b
processing, we used caspase-1-deficient BMDMs. Western
blots and ELISA assays demonstrated that the PMT-stimulated
release of cleaved IL-1b was not blocked through the absence
of caspase-1 (Figures 3B, 3C, and S2A). Additional experiments
revealed that other bacterial toxins (cytotoxic necrotizing factor y
[CNFy], CNF3) can use caspase-1-dependent and independent
pathways to produce IL-1b (Figures S2B and S2C).
To address the in vivo relevance of our findings, we injected
mice with PMT, LPS, or PBS. The mice were sacrificed, serum
was prepared, and organs (liver, spleen, and intestine) were
isolated and incubated for 24 hr in medium. IL-1b was detected
only in the liver of PMT-challenged animals (Figure 3D). IL-1b
processing occurred independently of the inflammasome, as
no caspase-1 activation was detected (Figure 3D). Equal loading
of protein was confirmed by a Ponceau red stain of the
membranes.
PMT Induces GrzA in Macrophages through the
JAK-STAT Pathway
We next investigated the potential influence of GrzA, a cytotoxic
protease that is released from cytotoxic T cells, natural killerNovember 6, 2014 ª2014 The Authors 911
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Figure 2. PMT Induces NF-lB Activation
TLR Independently through RhoA
(A) RAW264.7 cells were stimulated with PMT or
LPS, cytoplasmic and nuclear lysates were pre-
pared, and p65 was detected. As control, b-actin
and B23 were detected. Experiments were
repeated at least two times.
(B) EMSA analysis. DNA-protein complexes were
separated by electrophoresis and detected using a
p65 antibody. Experiments were repeated at least
two times.
(C–F) BMCs from Myd88-deficient, Trif-deficient,
and and wild-type (WT) mice were isolated and
macrophages were generated. After stimulation
with PMT (18 hr) or LPS (4 hr), RT-PCRs were
performed (C and D). Supernatants of cells treated
with PMT (18 hr) or LPS/ATP (4 hr/2 hr) were used
in IL-1b-ELISAs (E and F).
(G) Cells were transfected with an NF-lB-reporter
construct, treated with Ly27632 (15 mM) either
in parallel with PMT or 3 hr prior to LPS, and
stimulated overnight. Transcriptional activity was
analyzed, and results are presented as induction of
the unstimulated sample (C–G mean ± SD; n = 3).
(H) Cells were treated as described, and IL-1b was
determined in western blots (n = 3).cells, and eosinophiles (Anthony et al., 2010; Legrand et al.,
2010), which is discussed as an inflammatory protease. ELISAs
confirmed the expression and release of GrzA from RAW264.7
cells and BMDMs by PMT (Figure 3E) or CNF toxins, respectively
(Figure S2D), while LPS/ATP treatment caused no GrzA
induction.
Granzymes can be induced by STAT1 and STAT3 (Demoulin
et al., 1999). As PMT activates STATs (Orth et al., 2007), blocking
of the Janus kinase (JAK)-STAT pathway should elucidate a
possible dependency of Gzma induction. Incubation with the
JAK-inhibitor I (Calbiochem) (Figure S2E) abrogated toxin-
induced Gzma induction (Figure 3F), while it did not influence
the NF-kB-dependent expression of pro-IL-1b. However, it
selectively prevented PMT-stimulated processing of pro-IL-1b912 Cell Reports 9, 910–917, November 6, 2014 ª2014 The Authors(Figure 3G). Apart from Gzmb, no other
granzymes were found to be upregulated
by PMT (Figure S2F). Interestingly, this
GrzA-dependent mechanism is specific
for macrophages, as we found that hu-
man monocytes need the activation of
caspase-1 (Figures S2G and S2H).
PMT-Induced GrzA Processes
Pro-IL-1b into a Bioactive Form
To confirm the importance of GrzA, we
used Gzma- and Gzmb-deficient mice in
our studies. Figures 3H and 3I show that
PMT-stimulated IL-1b secretion is abol-
ished in GrzA-deficient macrophages,
but not in GrzB-deficient cells. To investi-
gate whether GrzA-processed IL-1b is an
active cytokine, we used EL4.NOB-1 cellsas a reporter system, as these cells secrete interleukin-2 (IL-2) in
response to IL-1b (Gearing et al., 1987). The supernatant of
PMT or LPS/ATP-stimulated RAW264.7 cells was applied to
EL4.NOB-1 cells. Figure 3J shows that PMT-generated IL-1b
triggered EL4.NOB-1 cells to produce IL-2, supporting our hy-
pothesis that GrzA is capable of processing pro-IL-1b into a
bioactive protein.
GrzA Enters Target Cells Perforin Independently and
Does Not Induce Cytotoxicity
To investigate whether GrzA processes IL-1b intracellularly or
whether a secretory pathway is involved, we inhibited exocy-
tosis with brefeldin A (BFA; Sigma). In contrast to the LPS/
ATP-mediated IL-1b cleavage, the PMT-induced activation
was abolished and the release of GrzA was blocked (Figures 4A
and 4B).
Although it is proposed that perforin mediates the uptake
of granzymes, perforin-independent ways have also been
described (Froelich et al., 1996; Motyka et al., 2000; Pinkoski
et al., 1998; Shi et al., 1997). To prove that GrzA is able to
enter macrophages without perforin, we used recombinant
human GrzA. Human monocytic THP-1 cells that had been
differentiated into macrophages were stimulated with LPS to
induce pro-IL-1b and treated with recombinant human GrzA
(Calbiochem) or were stimulated with PMT. Indeed, recombi-
nant GrzA was able to cleave LPS-induced pro-IL-1b into
mature IL-1b in the absence of an inflammasome trigger
(Figure 4C).
Perforin is thought to be the cause for the cytolytic function of
granzymes (Browne et al., 1999; Froelich et al., 1996). To check
whether GrzA would decrease the viability of macrophages, we
performed an apoptosis assay with human blood-derived mac-
rophages (Figures 4D and S3). Treatment with recombinant
GrzA lead to a 10% increase in apoptotic cells, but this slight dif-
ference dissolved after 30 hr and PMT-stimulated cells were
completely unaffected.
DISCUSSION
Macrophages sense conserved microbial structures and
induce a proinflammatory response via the secretion of cyto-
kines (Martinon and Tschopp, 2005). IL-1b is a master mediator
of inflammation that is produced through the activation of
receptors such as TLRs with subsequent NF-kB activation to
promote IL-1b gene transcription. We describe a mechanism
for the induction and maturation of the proinflammatory
cytokine IL-1b in mouse macrophages through Pasteurella mul-
tocida toxin independently of the inflammasome and caspase-
1-mediated pyroptosis. Using BMDMs from Myd88-deficient
mice, we show that PMT does not require TLR-signaling to
induce Il1b gene transcription but induces Il1b transcription
via RhoA-mediated NF-kB activation. After translation, IL-1b
needs to be processed into its bioactive form. Our data reveal
that caspase-1 is not responsible for PMT-triggered IL-1b acti-
vation. Despite the undisputable relevance of the inflamma-
some for the maturation of IL-1b, there is growing evidence
for caspase-1-independent activation modes. Studies on
turpentine-induced inflammation revealed that secretion of
mature IL-1b did not differ between Casp1-deficient and wild-
type mice (Fantuzzi et al., 1997). Furthermore, Casp1-deficient
mice were considerably less susceptible to Mycobacterium
tuberculosis infections than IL-1b-deficient mice (Mayer-Barber
et al., 2010), and in Chlamydia trachomatis infections, cas-
pase-1 contributes to bacterial-induced inflammatory pathol-
ogies without affecting the course of infection (Cheng et al.,
2008). Interestingly, inflammasome-independent IL-1b is
thought to play an important role in autoinflammatory bone dis-
ease and osteomyelitis (Lukens et al., 2014), which can be a
symptom after Pasteurella multocida infection (von Schroeder
and Bell, 1996).
Apart from caspase-1, a few other enzymes are discussed
to function as ICEs. Among these is caspase-8 (MaelfaitCet al., 2008), but experiments quantifying caspase-8 activity
excluded this possibility. Also, GrzA has been discussed as
an enzyme that induces a proinflammatory cytokine response
in fibroblasts and epithelial cells (Sower et al., 1996) and
the production of IL-1b in monocytic cells (Metkar et al.,
2008). Nevertheless, in the latter case, the induced secretion
of proinflammatory cytokines could be blocked by a cas-
pase-1-specific inhibitor. Interestingly, GrzA deficiency is
linked to reduced inflammation in helminth infection (Hartmann
et al., 2011). Our data show that PMT induces GrzA pro-
duction in RAW267.4 cells and in primary BMDMs in a
STAT3-dependent manner. Therefore, we hypothesize that
under STAT-activating conditions, macrophages can produce
GrzA, which can then convert pro-IL-1b into a bioactive
enzyme. Our results support the model of a perforin-indepen-
dent way of target cell entry by granzymes (Froelich et al.,
1996). In line with earlier findings (Metkar et al., 2008)
we claim that GrzA does not induce cytotoxicity in macro-
phages. PMT-induced inflammation therefore differs from the
normal course of bacterial infection in which macrophages
undergo cell death after activation due to caspase-1-mediated
pyroptosis.
Taken together, we propose that GrzA enters target cells
independently and functions as a mediator of inflammation by
IL-1b cleavage. It can be speculated that cytotoxic T cells
that lack perforin fail to kill target cells effectively but could still
regulate IL-1b secretion through exogenous GrzA. Indeed, the
majority of CD8+ T cells of the GALT (gut-associated lymphoid
tissue) express GrzA, but not perforin (Shacklett et al., 2004).
The absence of perforin-secreting T cells protects the integrity
of the mucosa under normal conditions but could also help
to induce macrophage-mediated inflammation by GrzA-pro-
cessed IL-1b.
IL-1b is linked to autoimmune disorders such as rheumatoid
arthritis (RA) (Bresnihan et al., 1998; Eastgate et al., 1988). A
key regulatory signaling cascade in inflammation-mediated
diseases is the JAK-STAT pathway (de Hooge et al., 2004;
Ivashkiv and Hu, 2003, 2004). The mechanism by which STAT
proteins contribute to the pathogenesis of RA is not fully clari-
fied, and a direct connection between STAT proteins and IL-1b
generation has not been considered so far. Interestingly, in a
study of induced inflammatory arthritis, caspase-1-deficient
mice developed joint swelling similar to wild-type mice (Joosten
et al., 2009). In this study, a neutrophil serine proteinase was
identified as an ICE in neutrophil-dominated inflammation,
and it can be speculated that during a macrophage-dominated
infection, STAT-induced GrzA could catalyze IL-1b maturation
and compensate for the caspase-1-deficiency. Compatible
with this, the levels of soluble GrzA are elevated in plasma
and synovial fluid of RA patients (Tak et al., 1999). Although
the publication assumes that cytotoxic T cells are the
source of GrzA, also macrophages, whose activation correlates
with the severity of RA (Kinne et al., 2000), could be of
importance. It is conceivable that in autoinflammatory dis-
eases, GrzA fulfills a relevant role as an ICE in macrophages
and possibly other cells of the innate immune system. How-
ever, our data show that human monocytes depend on the
caspase-1 pathway, which is in line with earlier studies (Metkarell Reports 9, 910–917, November 6, 2014 ª2014 The Authors 913
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Figure 3. PMT-Triggered Processing of Pro-IL-1b Is Mediated by GrzA and Occurs Independently of Caspase-1
(A) RAW264.7 cells were stimulated with PMT or LPS/ATP for the indicated time. Cleavage of caspase-1 was detected by western blot analysis (n = 5).
(B) BMDMs were generated from Casp1-deficient and WT mice, stimulated with PMT (18 hr) or LPS/ATP (4 hr/2 hr), and used for western blot analysis (n = 3).
(C) Supernatant from (B) was used in IL-1b-ELISAs.
(D) Mice were injected intraperitoneally with PMT (10 ng/g, 6.5 hr), LPS (25 mg/g, 3 hr), or PBS (mock). One-third of the isolated liver was incubated in medium at
37C for 24 hr. The amount of IL-1b and caspase-1 was detected by western blot analysis in the medium supernatant (n = 3).
(E) RAW264.7 cells or BMDMs were stimulated overnight with PMT or LPS. GrzA-ELISAs were performed.
(F) RAW264.7 cells were treated with 20 nM of JAK-inhibitor I 2 hr prior to PMT (6 hr) or LPS (4 hr) stimulation. Gzma sequence was measured by quantitative
RT-PCR.
(G) Lysates of supernatants and cells that were treated with 20 nM of JAK-inhibitor I 2 hr prior to PMT (overnight) or LPS/ATP (4 hr/2 hr) were produced and
western blot analyses were performed (n = 3).
(legend continued on next page)
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Figure 4. GrzA Enters Target Cells Perforin Independently and Does Not Induce Cytotoxicity
(A and B) RAW264.7 cells were treated with 30 mM brefeldin (BFA) 2 hr before stimulation with PMT (overnight), only with PMT or BFA, or with LPS/ATP (4 hr/
2 hr) ± BFA. IL-1b was detected by immunoblotting (A) (n = 3). Supernatants were used for GrzA-ELISAs (B).
(C) THP-1 cells were differentiated with 500 ng/ml PMA into macrophages, stimulated with LPS (2 hr), and treated with 100 ng/ml human recombinant GrzA
overnight. Controls: unstimulated, LPS, huGrzA, PMT. IL-1b was detected by ELISAs (B and C, mean ± SD; n = 3).
(D) Human blood-derived macrophages were generated and treated with PMT, recombinant GrzA (100 ng/ml), staurosporine (1 mM), doxorubicin (1 mM), or
LPS/ATP. Cells were stained with Annexin V-FITC and propidium iodide (PI) and analyzed by flow cytometry. A caspase-3/7 assay is shown in Figure S3.et al., 2008), while human blood-derived macrophages do not
(Figures S2G and S2H).EXPERIMENTAL PROCEDURES
Mouse Experiments
All animal experiments were performed in compliance with the German animal
protection law (TierSchG). The animals were housed and handled in accor-
dance with good animal practice as defined by FELASA (http://www.felasa.
eu/guidelines.php) and the national animal welfare body GV-SOLAS (http://
www.gv-solas.de). The animal welfare committees of the University of Frei-(H and I) BMDMs from Gmza- and Gmzb-deficient and WT mice were stimula
immunoblotting (n = 3).
(I) Supernatant was used in IL-1b-ELISAs.
(J) EL4.NOB-1 cells were cultured with supernatants of PMT- or LPS/ATP-stimul
IL-2 was measured with ELISAs.
In (C), (E), (F), (I), and (J), data are mean ± SD (n = 3). Figure S2 shows further ex
Cburg as well as the local authorities (Regierungspra¨sidium Freiburg) approved
all animal experiments.
ELISA
Mouse and human IL-1b ELISA Set (BD OptEIA), mouse IL-2 ELISA MAX
Standard SET (BioLegend), or human granzyme A (USCN Life Science) was
used. Measurements were performed on a Tecan GENios Pro plate reader
and analyzed with Magellan5 software.
Immunoblot Analysis
To determine p65 activation, cells were lysed as described before (Hildebrand
et al., 2010) and analyzed by western blotting. For determination of IL-1b,ted with PMT (o.n.) or LPS/ATP (4 hr/2 hr). In (H), lysates were analyzed by
ated RAW264.7 cells or stimulated with PMT, LPS/ATP, or recombinant IL-1b.
periments regarding caspase-1, GrzA, and other bacterial toxins.
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lysates of cells and supernatants were produced with 10X RIPA buffer. Anti-
bodies used were p65, actin, and anti-rabbit horseradish peroxidase (HRP)
from Cell Signaling Technology and IL-1b (R20), caspase-1p10, and anti-
goat-HRP from Santa Cruz Biotechnology. Samples were boiled in Laemmli
buffer and separated on a 4%–20% gradient polyacrylamid gel (Anamed
GmbH) via SDS-PAGE, transferred to nitrocellulose, and immunoblotted
(primary antibody 1:1,000, HRP-coupled secondary antibody 1:5,000).
RT-PCR
RNA was extracted with the High pure RNA Isolation Kit (Roche). cDNA
was prepared using the Reversed Aid First Strand cDNA Synthesis Kit
(Fermentas Life Science).Quantitative RT-PCR analysis were performed
with the SYBR green Rox mix (Thermo Scientific). For primers used, see
Supplemental Experimental Procedures. Results were analyzed using
the Fast Real-Time PCR System (Applied Biosystems). The mean values
of the results were normalized against the housekeeping genes Gapdh
or actin.
EMSA
Nuclear extracts were prepared as described previously (Andrews and Faller,
1991), and 3 mg protein was incubated with 40 fmol of a Cy 5-labeled DNA
probe (NF-lB-probe 5-Cy, 50-AGTTGAGGGGACTTTCCCAGGC-30 ) in gel shift
incubation buffer (20 mM HEPES [pH 7.8], 50 mM KCI, 50 mM EDTA, 1 mM
MgCl2, 5% glycerol, 0.5 mM dithiothreitol, 0.2 mg/ml poly[dI-dC] [Pharmacia])
for 10 min at room temperature. DNA-protein complexes were separated on a
4% polyacrylamide gel containing 15% glycerol in 0.5X Tris borate EDTA
buffer. After electrophoresis, the EMSA was developed with a Typhoon Trio
Variable Mode Imager (GE Healthcare Life Sciences).
Cytotoxicity Assay
Annexin-V-FLUOS Staining Kit (Roche) was used. Annexin-V fluorescein iso-
thiocyanate (FITC) and propidium iodide-positive cells were quantified by
flow cytometry on a FACSCanto.
Luciferase Assay
NF-lB transcriptional activity was measured with a pNF-kB reporter
plasmid (Promega). Cells were transfected with LF2000 (Invitrogen). After
4 hr, medium was changed and cells were stimulated. Cells were lysed
24 hr after transfection, and luciferase assays were performed with the
dual luciferase reporter assay (Promega) and a luminometer (Plate Chame-
leon, HIDEX).
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